Cargando…
Paraskeletal and extramedullary plasmacytomas in multiple myeloma at diagnosis and at first relapse: 50-years of experience from an academic institution
From January 1970 to December 2018, 1304 patients were diagnosed with multiple myeloma (MM) at our institution and 256 (19.6%) had plasmacytomas (Ps) (paraskeletal –PPs- 17.6%, extramedullary –EMPs-1.9%). Patients with Ps had lower serum M-protein and less advanced ISS stage than those without. At f...
Autores principales: | Jiménez-Segura, Raquel, Rosiñol, Laura, Cibeira, Ma Teresa, Fernández de Larrea, Carlos, Tovar, Natalia, Rodríguez-Lobato, Luis Gerardo, Bladé, Esther, Moreno, David F., Oliver-Caldés, Aina, Bladé, Joan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481598/ https://www.ncbi.nlm.nih.gov/pubmed/36114167 http://dx.doi.org/10.1038/s41408-022-00730-5 |
Ejemplares similares
-
Outcomes of Patients with Newly Diagnosed Transplant-Ineligible Multiple Myeloma According to Clinical Trials Enrollment: Experience of a Single Institution
por: Rodríguez-Lobato, Luis Gerardo, et al.
Publicado: (2023) -
Long-Term Responders After Autologous Stem Cell Transplantation in Multiple Myeloma
por: Oliver-Caldes, Aina, et al.
Publicado: (2022) -
Treatment of Patients with Monoclonal Gammopathy of Clinical Significance
por: Moreno, David F., et al.
Publicado: (2021) -
A serum microRNA signature associated with complete remission and progression after autologous stem-cell transplantation in patients with multiple myeloma
por: Navarro, Alfons, et al.
Publicado: (2015) -
First report of CART treatment in AL amyloidosis and relapsed/refractory multiple myeloma
por: Oliver-Caldes, Aina, et al.
Publicado: (2021)